RecruitingNCT06835504
Ketamine or morphine for acute pain in children
About this title
Read the official source — NCT06835504Medication studyAges 6–17United StatesPTSD
Understand this study
Who could participate?
Listed age limits: 6 years to 17 years.
What will I do during this study?
Depending on the assigned group, the study provides ketamine or morphine through a vein for pain treatment.
- Listed locations
- Los Angeles and 7 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: October 17, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 1,010
- Sponsor
- Columbia University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 6 Years to 17 Years
- Official registry ID
- NCT06835504
- Official title
Show the full official title
Efficacy of Intravenous Sub-Dissociative Ketamine Versus Intravenous Morphine in Children With Acute Pain
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Los Angeles · Sacramento · Wilmington
5 more locations
- Atlanta
- New York
- Pittsburgh
- Seattle
- Milwaukee
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Columbia University, a university.
Does this study involve medication?
Yes. The study involves medication, including Ketamine hydrochloride and Morphine sulphate.
Who can participate?
Listed age limits: 6 years to 17 years.
Is this study still recruiting?
The registry lists this study as recruiting.
